首页> 外文期刊>European radiology >Reliable categorisation of visual scoring of coronary artery calcification on low-dose CT for lung cancer screening: Validation with the standard Agatston score
【24h】

Reliable categorisation of visual scoring of coronary artery calcification on low-dose CT for lung cancer screening: Validation with the standard Agatston score

机译:低剂量CT上冠状动脉钙化视觉评分的可靠分类可用于肺癌筛查:使用标准Agatston评分进行验证

获取原文
获取原文并翻译 | 示例
           

摘要

Objectives: To validate the reliability of the visual coronary artery calcification score (VCACS) on low-dose CT (LDCT) for concurrent screening of CAC and lung cancer. Methods: We enrolled 401 subjects receiving LDCT for lung cancer screening and ECG-gated CT for the Agatston score (AS). LDCT was reconstructed with 3- and 5-mm slice thickness (LDCT-3mm and LDCT-5mm respectively) for VCACS to obtain VCACS-3mm and VCACS-5mm respectively. After a training session comprising 32 cases, two observers performed four-scale VCACS (absent, mild, moderate, severe) of 369 data sets independently, the results were compared with four-scale AS (0, 1-100, 101-400, >400). Results: CACs were present in 39.6 % (146/369) of subjects. The sensitivity of VCACS-3mm was higher than for VCACS-5mm (83.6 % versus 74.0 %). The median of AS of the 24 false-negative cases in VCACS-3mm was 2.3 (range 1.1-21.1). The false-negative rate for detecting AS ≥ 10 on LDCT-3mm was 1.9 %. VCACS-3mm had higher concordance with AS than VCACS-5mm (k = 0.813 versus k = 0.685). An extended test of VCACS-3mm for four junior observers showed high inter-observer reliability (intra-class correlation = 0.90) and good concordance with AS (k = 0.662-0.747). Conclusions: This study validated the reliability of VCACS on LDCT for lung cancer screening and showed that LDCT-3mm was more feasible than LDCT-5mm for CAD risk stratification. Key Points: ? Low-dose computed tomography (LDCT) rarely misses significant coronary artery calcification (CAC). ? Visual scoring of CAC on LDCT is highly concordant with Agatston scoring. ? LDCT-3mm is more feasible than LDCT-5mm for CAD risk stratification. ? CAC assessment enriched the screening information for LDCT lung cancer screening.
机译:目的:验证低剂量CT(LDCT)上的可视冠状动脉钙化评分(VCACS)的同时筛查CAC和肺癌的可靠性。方法:我们招募了401名接受LDCT进行肺癌筛查和ECG门控CT进行Agatston评分(AS)的受试者。 LDCT的切片厚度分别为3和5毫米(分别为LDCT-3mm和LDCT-5mm)用于VCACS,分别获得VCACS-3mm和VCACS-5mm。经过32个案例的培训后,两名观察员分别对369个数据集进行了四级VCACS(不存在,轻度,中度,严重),将结果与四级AS(0、1-100、101-400, > 400)。结果:CACs出现在39.6%(146/369)的受试者中。 VCACS-3mm的灵敏度高于VCACS-5mm(83.6%对74.0%)。 VCACS-3mm中24例假阴性病例的AS中位数为2.3(范围1.1-21.1)。在LDCT-3mm上检测到AS≥10的假阴性率为1.9%。 VCACS-3mm与AS的一致性比VCACS-5mm高(k = 0.813对k = 0.685)。对四个初级观察者进行的VCACS-3mm扩展测试显示,观察者之间的可靠性较高(类内相关度= 0.90),并且与AS的一致性良好(k = 0.662-0.747)。结论:这项研究证实了VCACS在LDCT上进行肺癌筛查的可靠性,并表明LDCT-3mm比LDCT-5mm更可行进行CAD风险分层。关键点: ?低剂量计算机断层扫描(LDCT)很少会漏掉明显的冠状动脉钙化(CAC)。 ? LDCT上CAC的视觉评分与Agatston评分高度一致。 ?对于CAD风险分层,LDCT-3mm比LDCT-5mm更可行。 ? CAC评估丰富了用于LDCT肺癌筛查的筛查信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号